FY26-pharmacy adempas
Ended Awarded Last action
- Contract number
- 15B50926F00000077
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Federal Correctional Institution Fort Worth
Correctional Facilities, Department of Justice
- Obligated
- $12,396
Award facts
- Contract value 100% obligated
- $12,396.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$12,396 | |
| Original award | $24,792 |
About this award
The Federal Correctional Institution Fort Worth issued a delivery order to Bayer Healthcare Pharmaceuticals Inc. on April 1, 2026, for Adempas (riociguat), a specialty pharmaceutical used to treat pulmonary arterial hypertension. This firm fixed-price delivery order, valued at $12,396.11, is due for completion by April 30, 2026, and was issued without a small business set-aside designation. The award is issued under the parent $840 million Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs maintained by Bayer Healthcare Pharmaceuticals Inc. with the Department of Veterans Affairs, which enables federal agencies to procure pharmaceutical products at pre-negotiated pricing. The place of performance is located in Whippany, New Jersey, where Bayer maintains its principal pharmaceutical operations.
Bayer Healthcare Pharmaceuticals Inc., a subsidiary of Germany-based Bayer AG, is a major supplier of specialized pharmaceutical products to the federal government, with established expertise in oncology drugs, radiopharmaceuticals, cardiovascular treatments, and other critical medications. The company's federal contracting portfolio spans multiple agencies including the Department of Veterans Affairs, Defense Logistics Agency, Department of Defense, and the Bureau of Prisons, reflecting its role as a reliable supplier of single-source and limited-availability medications essential to federal healthcare programs. This delivery order supports the correctional facility's pharmaceutical supply requirements through an established indefinite delivery vehicle that streamlines procurement of critical medications.
Quick answers
Who was awarded contract 15B50926F00000077?
15B50926F00000077 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Federal Correctional Institution Fort Worth (Correctional Facilities) on April 1, 2026.
How much is contract 15B50926F00000077 worth?
The government has obligated $12,396 on 15B50926F00000077.
Is contract 15B50926F00000077 an order under another contract?
Yes. 15B50926F00000077 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50926F00000077 competed?
The extent of competition for 15B50926F00000077 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award